Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-24-007870

CHIEF OPERATING OFFICER gave up 478 shares (to pay taxes)

  • CHIEF OPERATING OFFICER acquired 1,227 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Williams Paul Christopher CHIEF OPERATING OFFICER 2024-03-11 Option exercise +1,227 5,795 D
Williams Paul Christopher CHIEF OPERATING OFFICER 2024-03-11 Shares withheld for taxes −478 $7.22 $3,451 5,317 D
Derivatives
Williams Paul Christopher CHIEF OPERATING OFFICER 2024-03-11 Option exercise · Restricted Stock Units −1,227 11,046 D
Loading xslF345X05/form4-03132024_100335.xml…